Dalton Expands Canadian Manufacturing Facility

1 Sep

pharmtech.com 30 Aug, 2016

 

Dalton Pharma Services completed a $5-million expansion in sterile filling and API manufacturing at its cGMP facility in Toronto, Canada. The project added three new sterile processing suites and an API manufacturing suite, and it included the addition of a semi-automated powder filling line with significant scale-up of lyophilization capacity. This project has been supported by C$2.085 million (Canadian Dollars) in business growth funding from the Canadian government, combined with the company’s initial investment of C$3.5 million for a total investment at the site to more than C$5 million.

Leave a Reply

Your email address will not be published. Required fields are marked *